CNTO 1959

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CNTO 1959, covering 2014-12-19 to 2017-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2]

See pricing